GENOVIS: ANNOUNCEMENT OF ANNUAL REPORT 2007

GENOVIS: ANNOUNCEMENT OF ANNUAL REPORT  2007 

The complete annual report 2007, will as from April 4, 2008 be available at the
company's webpage www.genovis.com and at the company's head office, address
Scheelevägen 19F, SE-211 19, Lund, Sweden. The annual report may also be
obtained from the company via telephone, +46-46 10 12 38. 

The annual report in English will be available at the company's webpage April 8,
2008.



Find out more, contact:
Sarah Fredriksson, CEO, Genovis AB
Tel: +46 46 10 12 30
sarah.fredriksson@genovis.com



Genovis is a biotechnology company with distinguished core competency in the
fields of nanotechnology and nanoparticles. The company's patented NIMT®
technology (NanoInducedMagneticTransfer) has been developed in order to enable
the life science industry to conduct effective preclinical research. Genovis
shares are listed on the First North, part of OMX Nordic Exchange. Mangold
Fondkommission AB is a Certified Advisor and guarantor of liquidity to the
company.